OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $630,460 Invested

2021

Life Biosciences

Sharon Rosenzweig-Lipson, PhD

Effects of Chaperone-Mediated Autophagy in Alzheimer's Disease

  • Funding Amount: $630,460
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Proteostasis
  • Status: Active